Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2896068rdf:typepubmed:Citationlld:pubmed
pubmed-article:2896068lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:2896068lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:2896068lifeskim:mentionsumls-concept:C0868928lld:lifeskim
pubmed-article:2896068lifeskim:mentionsumls-concept:C2827424lld:lifeskim
pubmed-article:2896068lifeskim:mentionsumls-concept:C0039260lld:lifeskim
pubmed-article:2896068lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:2896068pubmed:issue10lld:pubmed
pubmed-article:2896068pubmed:dateCreated1988-6-7lld:pubmed
pubmed-article:2896068pubmed:abstractTextPostthymic T-cell malignancy shows marked geographic, clinicopathologic, and prognostic diversity. The frequency and spectrum of T-cell malignancies in Taiwan were investigated. Fifty-two patients (35 male and 17 female) with a median age of 49 years, were consecutively encountered between October 1983 and April 1987; these accounted for 39% of non-Hodgkin's lymphoma cases seen in our institutions. Ten patients (19.3%) had adult T-cell leukemia/lymphoma (ATL) associated with human T-cell leukemia virus (HTLV-1). Patients with ATL had disease similar to that reported from southwestern Japan and the Caribbean. They had frequent skin lesions (60%), hypercalcemia (40%), and a rapid clinical course with a median survival of 1.3 years. The 35 HTLV-1-negative peripheral T-cell lymphomas (PTL) were similar to PTL in western countries, manifesting frequent visceral, cutaneous, and vascular tropisms. Marrow involvement was documented at presentation in 39% and Stage III/IV disease in 80% of the PTL patients. The histology of PTL usually expressed prominent reactive features which is distinct from that in ATL. Several subcategories could be defined: Hodgkin's-like PTL in nine patients, T-zone lymphoma in three, angioimmunoblastic lymphadenopathy-like lymphoma in one, Lennert's lymphoma in three, and angioinvasive lymphoma in four. Two HTLV-1-negative PTL had neoplastic cells with clover-shaped nuclei and were designated as ATL-like. Morphologic classification based on the modified Working Formulation showed prognostic correlation, with median survival of less than 6 months for large cell/immunoblastic PTL, compared with 5 years for patients with small/medium cell PTL. Both low- and high-grade PTL seem to represent an incurable disease. Classical cutaneous T-cell lymphoma (seven cases) is relatively unusual in Taiwan, compared with the frequency of PTL. Post-thymic T-cell malignancies in Taiwan include HTLV-1-positive and HTLV-1-negative diseases, both of which have a poor prognosis and resemble similar T-cell malignancies in the East and West.lld:pubmed
pubmed-article:2896068pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2896068pubmed:languageenglld:pubmed
pubmed-article:2896068pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2896068pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2896068pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2896068pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2896068pubmed:statusMEDLINElld:pubmed
pubmed-article:2896068pubmed:monthMaylld:pubmed
pubmed-article:2896068pubmed:issn0008-543Xlld:pubmed
pubmed-article:2896068pubmed:authorpubmed-author:HoC SCSlld:pubmed
pubmed-article:2896068pubmed:authorpubmed-author:ChenY CYClld:pubmed
pubmed-article:2896068pubmed:authorpubmed-author:WangC HCHlld:pubmed
pubmed-article:2896068pubmed:authorpubmed-author:HuangS SSSlld:pubmed
pubmed-article:2896068pubmed:authorpubmed-author:SuI JIJlld:pubmed
pubmed-article:2896068pubmed:authorpubmed-author:ChenC JCJlld:pubmed
pubmed-article:2896068pubmed:authorpubmed-author:HsiehH CHClld:pubmed
pubmed-article:2896068pubmed:authorpubmed-author:TienH FHFlld:pubmed
pubmed-article:2896068pubmed:authorpubmed-author:ChengA LALlld:pubmed
pubmed-article:2896068pubmed:authorpubmed-author:Woei-Tsaylld:pubmed
pubmed-article:2896068pubmed:issnTypePrintlld:pubmed
pubmed-article:2896068pubmed:day15lld:pubmed
pubmed-article:2896068pubmed:volume61lld:pubmed
pubmed-article:2896068pubmed:ownerNLMlld:pubmed
pubmed-article:2896068pubmed:authorsCompleteNlld:pubmed
pubmed-article:2896068pubmed:pagination2060-70lld:pubmed
pubmed-article:2896068pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2896068pubmed:meshHeadingpubmed-meshheading:2896068-...lld:pubmed
pubmed-article:2896068pubmed:meshHeadingpubmed-meshheading:2896068-...lld:pubmed
pubmed-article:2896068pubmed:meshHeadingpubmed-meshheading:2896068-...lld:pubmed
pubmed-article:2896068pubmed:meshHeadingpubmed-meshheading:2896068-...lld:pubmed
pubmed-article:2896068pubmed:meshHeadingpubmed-meshheading:2896068-...lld:pubmed
pubmed-article:2896068pubmed:meshHeadingpubmed-meshheading:2896068-...lld:pubmed
pubmed-article:2896068pubmed:meshHeadingpubmed-meshheading:2896068-...lld:pubmed
pubmed-article:2896068pubmed:meshHeadingpubmed-meshheading:2896068-...lld:pubmed
pubmed-article:2896068pubmed:meshHeadingpubmed-meshheading:2896068-...lld:pubmed
pubmed-article:2896068pubmed:meshHeadingpubmed-meshheading:2896068-...lld:pubmed
pubmed-article:2896068pubmed:meshHeadingpubmed-meshheading:2896068-...lld:pubmed
pubmed-article:2896068pubmed:meshHeadingpubmed-meshheading:2896068-...lld:pubmed
pubmed-article:2896068pubmed:meshHeadingpubmed-meshheading:2896068-...lld:pubmed
pubmed-article:2896068pubmed:meshHeadingpubmed-meshheading:2896068-...lld:pubmed
pubmed-article:2896068pubmed:year1988lld:pubmed
pubmed-article:2896068pubmed:articleTitleCharacterization of the spectrum of postthymic T-cell malignancies in Taiwan. A clinicopathologic study of HTLV-1-positive and HTLV-1-negative cases.lld:pubmed
pubmed-article:2896068pubmed:affiliationDepartment of Pathology, College of Medicine, National Taiwan University, Taipei, Republic of China.lld:pubmed
pubmed-article:2896068pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2896068pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2896068pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2896068pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2896068lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2896068lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2896068lld:pubmed